Smith & Nephew (NYSE:SNN) Downgraded to Neutral Rating by UBS Group

Smith & Nephew (NYSE:SNN - Get Free Report) was downgraded by UBS Group from a "buy" rating to a "neutral" rating in a note issued to investors on Wednesday,Briefing.com Automated Import reports.

Other analysts also recently issued research reports about the stock. Canaccord Genuity Group reaffirmed a "hold" rating and set a $27.00 price target on shares of Smith & Nephew in a report on Wednesday, February 26th. StockNews.com upgraded shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, February 26th. Four equities research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $27.00.

Smith & Nephew Stock Performance

Shares of SNN stock opened at $29.87 on Wednesday. The company's 50-day moving average is $26.10 and its 200 day moving average is $27.17. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The company has a market capitalization of $13.06 billion, a price-to-earnings ratio of 13.83, a price-to-earnings-growth ratio of 1.26 and a beta of 0.83. Smith & Nephew has a one year low of $23.65 and a one year high of $31.72.

Institutional Investors Weigh In On Smith & Nephew

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. River Road Asset Management LLC raised its position in shares of Smith & Nephew by 64.0% during the fourth quarter. River Road Asset Management LLC now owns 2,032,016 shares of the medical equipment provider's stock valued at $49,947,000 after buying an additional 792,829 shares during the last quarter. J. Goldman & Co LP purchased a new position in shares of Smith & Nephew in the fourth quarter valued at $47,700,000. Brandes Investment Partners LP grew its holdings in shares of Smith & Nephew by 11.4% in the fourth quarter. Brandes Investment Partners LP now owns 1,363,039 shares of the medical equipment provider's stock valued at $33,504,000 after purchasing an additional 138,994 shares in the last quarter. Clark Estates Inc. NY grew its holdings in shares of Smith & Nephew by 16.8% in the fourth quarter. Clark Estates Inc. NY now owns 800,000 shares of the medical equipment provider's stock valued at $19,664,000 after purchasing an additional 115,000 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its holdings in shares of Smith & Nephew by 11.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 535,350 shares of the medical equipment provider's stock valued at $13,159,000 after purchasing an additional 57,014 shares in the last quarter. Institutional investors own 25.64% of the company's stock.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Remove Ads